Most of the ADCs currently in clinical use rely on effective internalization and intracellular lysosome transport to achieve bio-cleavage of linkers to release drugs. And, the cleavaged drug must escape from the lysosome to achieve its therapeutic effect. However, not all tumor antigens can ensure the effective ADC treatment described above, especially in solid tumors. Besides,...